Inventor
POZZI DAVIDE
CH11 patents
⚠️ This page may combine multiple inventors who share the name “POZZI DAVIDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDORSIA PHARMACEUTICALS LTD
6 patentsUS11241431B2Feb 8, 2022
N-substituted indole derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD6 citations83
US11325899B2May 10, 2022
Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD6 citations73
US11712438B2Aug 1, 2023
Phenyl derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations71
US11446298B2Sep 20, 2022
Pyrimidine derivatives
IDORSIA PHARMACEUTICALS LTD5 citations71
US12011444B2Jun 18, 2024
N-substituted indole derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD2 citations70
US11839613B2Dec 12, 2023
Pyrimidine derivatives as PGE2 receptor modulators
IDORSIA PHARMACEUTICALS LTD1 citations61
ACTELION PHARMACEUTICALS LTD
4 patentsUS9663473B2May 30, 2017
Benzimidazolyl-methyl urea derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD1 citations51
US9139524B2Sep 22, 2015
Fluorinated bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD1 citations51
US9676761B2Jun 13, 2017
Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD0 citations50
US9533964B2Jan 3, 2017
Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists
ACTELION PHARMACEUTICALS LTD0 citations50